Invesco Ltd. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,060,663
-43.3%
1,044,721
-37.3%
0.00%
-40.0%
Q2 2023$17,735,093
-4.1%
1,666,832
-5.2%
0.01%0.0%
Q1 2023$18,502,514
-12.3%
1,758,794
+3.3%
0.01%
-16.7%
Q4 2022$21,102,772
+21.6%
1,703,210
+1.7%
0.01%0.0%
Q3 2022$17,358,000
+24.4%
1,675,528
+38.5%
0.01%
+50.0%
Q2 2022$13,954,000
+63.0%
1,210,200
+77.8%
0.00%
+100.0%
Q1 2022$8,560,000
-3.7%
680,466
-10.7%
0.00%0.0%
Q4 2021$8,887,000
-3.0%
762,182
+8.7%
0.00%0.0%
Q3 2021$9,159,000
-0.4%
701,277
-1.8%
0.00%0.0%
Q2 2021$9,192,000
-11.3%
714,201
-22.9%
0.00%
-33.3%
Q1 2021$10,359,000
+56.3%
926,526
+59.2%
0.00%
+50.0%
Q4 2020$6,629,000
+6.7%
581,959
-15.7%
0.00%0.0%
Q3 2020$6,212,000
-21.1%
690,615
-9.5%
0.00%
-33.3%
Q2 2020$7,878,000
+32.2%
763,318
+29.2%
0.00%0.0%
Q1 2020$5,959,000
+781.5%
590,577
+1063.5%
0.00%
Q4 2019$676,000
-88.5%
50,757
-92.6%
0.00%
-100.0%
Q3 2019$5,876,000
+3666.7%
684,378
+5824.8%
0.00%
Q1 2019$156,000
+38.1%
11,551
+6.1%
0.00%
Q4 2018$113,000
-98.7%
10,886
-97.7%
0.00%
-100.0%
Q3 2018$8,785,000
+46.2%
475,914
+49.5%
0.00%
+50.0%
Q2 2017$6,010,000
+10086.4%
318,323
+6439.1%
0.00%
Q2 2015$59,000
+110.7%
4,868
+70.3%
0.00%
Q2 2013$28,0002,8580.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders